The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vaniqa 11.5%

Almirall, S.A.EU/1/01/173/001

Main Information

Trade NameVaniqa 11.5%
Active SubstancesEflornithine
Dosage FormCream
Licence HolderAlmirall, S.A.
Licence NumberEU/1/01/173/001

Group Information

ATC CodeP01CX Other agents against leishmaniasis and trypanosomiasis
P01CX03 eflornithine


License statusAuthorised
Licence Issued28/03/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back